Skip to main content
Equibles
CVS logo

CVS · CVS HEALTH Corp · Metrics

Track CVS — free

Use CVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$86.46 +1.26 (+1.48%) At close · Oct 2
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$110.82B
Shares
1.28B
Volume · Oct 2 10.46M Avg daily vol (3M) 7.72M

CVS metrics

83 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$86.46
Market cap
$110.82B

Price action

20 metrics
Price change (1W)
-3.0%
Price change (30D)
-11.0%
Price change (3M)
-17.4%
Price change (6M)
+17.6%
Price change (YTD)
+8.9%
Price change (1Y)
+11.6%
Trailing year
Price change (5Y)
+2.8%
52-week high
$110.60
52-week low
$70.08
Change from 52-week high
-21.8%
Change from 52-week low
+23.4%
Annualized volatility
31.2%
Annualized volatility (3M)
27.2%
Beta
0.2
RSI (14D)
37.0
Price vs SMA 50
-8.9%
Price vs SMA 200
-1.4%
Avg volume (3M)
7.72M
Relative volume
1.4
Average dollar volume
$748.77M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
1.28B

Valuation

12 metrics
P / E (TTM)
22.8
Trailing earnings · reciprocal yield 4.4%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 374.6%
P / book
1.4
reciprocal yield 71.9%
FCF yield
10.6%
TTM · current market cap
Buyback yield
0.0%
P / FCF
9.4
reciprocal yield 10.6%
P / operating cash flow
7.5
reciprocal yield 13.3%
Earnings yield
4.4%

Historical valuation

8 metrics
P / E historical average (3Y)
36.6×
reciprocal yield 2.7%
P / E historical average (5Y)
31.7×
reciprocal yield 3.1%
EV / revenue historical average (3Y)
0.4×
reciprocal yield 265.5%
EV / revenue historical average (5Y)
0.4×
reciprocal yield 229.9%
EV / EBIT historical average (3Y)
17.8×
reciprocal yield 5.6%
EV / EBIT historical average (5Y)
17.5×
reciprocal yield 5.7%
EV / EBITDA historical average (3Y)
11.3×
reciprocal yield 8.8%
EV / EBITDA historical average (5Y)
11.4×
reciprocal yield 8.8%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
69.9%
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
2.0%
Trailing 12 months
Net margin
1.2%
Gross profit (TTM)
$29.29B
Operating profit (TTM)
$8.29B
Net income (TTM)
$4.89B
Trailing 12 months
Diluted EPS (TTM)
$3.79
FCF margin
2.8%
Effective tax rate
15.6%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$59.18

Growth

11 metrics
Revenue growth YoY
+7.3%
Year over year
Net income growth YoY
+191.8%
Revenue (TTM)
$415.09B
Trailing 12 months
EPS growth YoY
+188.8%
Shares change YoY
+1.3%
Year over year · more shares
Revenue CAGR (3Y)
+7.6%
Revenue CAGR (5Y)
+8.4%
EPS CAGR (3Y)
-24.7%
EPS CAGR (5Y)
-23.9%
FCF CAGR (3Y)
-16.6%
FCF CAGR (5Y)
-10.3%

Quality

14 metrics
Return on equity
6.1%
Return on assets
1.9%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
$12.81B
Free cash flow (TTM)
$11.76B
Quick ratio
0.7
Interest coverage
2.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$11.33B
Total assets
$253.77B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$14.78B
Capital expenditures (TTM)
$3.02B
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$715.00M
R&D / revenue
—
Stock compensation / revenue
0.2%

Ownership (13F)

3 metrics
13F filers
2,087
13F filer change QoQ
+197
Institutional ownership
91.4%

Short interest

3 metrics
Short interest
1.3%
Latest settlement · 3.1 days to cover
Days to cover
3.1d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 64803 CUSIP 126650100 13F (30d) 53 filings 32 filers Visit website Investor relations